Alligator Bioscience AB: Interim report January-September 2021

/PRNewswire/ -- First Patient Dosed in Optimize-1 Phase II "We continued to make great strides in the third quarter of 2021. The first patient was dosed in...

Related Keywords

China ,Sweden ,Finland ,Stockholm ,United Kingdom ,France ,Belgium ,Finnish ,Julie Silber ,Marie Svensson ,Aptevo Therapeutics Inc ,Shanghai Henlius Biotech Inc ,Macrogenics Inc ,Orion Corporation ,Biotheus Inc ,Patient Dosed ,Senior Director ,Investor Relations ,Wall Street ,Scandion Oncology ,Henlius Biotech ,Alligator Bioscience ,Aptevo Therapeutics ,Shanghai Henlius Biotech ,Nasdaq Stockholm ,